After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP

By
A A A

The following companies are expected to report earnings after hours on 03/12/2013. Visit our Earnings Calendar for a full list of expected earnings releases.

Kennedy-Wilson Holdings Inc. ( KW ) is reporting for the quarter ending December 31, 2012. The real estate company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-0.08. This value represents a -161.54% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for KW is -53.38 vs. an industry ratio of 10.90.

Dole Food Company, Inc ( DOLE ) is reporting for the quarter ending December 31, 2012. The food company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.01. This value represents a -50.00% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for DOLE is 12.40 vs. an industry ratio of 20.10.

ACADIA Pharmaceuticals Inc. ( ACAD ) is reporting for the quarter ending December 31, 2012. The biomedical (gene) company's consensus earnings per share forecast from the 5 analysts that follow the stock is $-0.08. This value represents a -20.00% decrease compared to the same quarter last year. ACAD missed the consensus earnings per share in the 1st calendar quarter of 2012 by -9.09%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for ACAD is -18.51 vs. an industry ratio of -11.40.

Global Cash Access Holdings, Inc. ( GCA ) is reporting for the quarter ending December 31, 2012. The financial services company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.16. This value represents a 14.29% increase compared to the same quarter last year. GCA missed the consensus earnings per share in the 1st calendar quarter of 2012 by -4.76%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for GCA is 8.57 vs. an industry ratio of 22.40.

GenMark Diagnostics, Inc. ( GNMK ) is reporting for the quarter ending December 31, 2012. The medical instruments company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-0.23. This value represents a -14.81% decrease compared to the same quarter last year. GNMK missed the consensus earnings per share in the 4th calendar quarter of 2011 by -3.85%. The "days to cover" for this stock exceeds 22 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for GNMK is -11.87 vs. an industry ratio of 121.50.

Avid Technology, Inc. ( AVID ) is reporting for the quarter ending December 31, 2012. The computer software company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.11. This value represents a -63.33% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for AVID is -15.44 vs. an industry ratio of 17.40.

Whitestone REIT ( WSR ) is reporting for the quarter ending December 31, 2012. The reit company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.25. This value represents a no change for the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for WSR is 16.23 vs. an industry ratio of 16.30.

Kratos Defense & Security Solutions, Inc. ( KTOS ) is reporting for the quarter ending December 31, 2012. The aerospace and defense company's consensus earnings per share forecast from the 7 analysts that follow the stock is $-0.05. This value represents a -129.41% decrease compared to the same quarter last year. In the past year KTOS has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 550%. The "days to cover" for this stock exceeds 22 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for KTOS is -7.86 vs. an industry ratio of 37.60.

Geron Corporation ( GERN ) is reporting for the quarter ending December 31, 2012. The biomedical (gene) company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.14. This value represents a -36.36% decrease compared to the same quarter last year. GERN missed the consensus earnings per share in the 4th calendar quarter of 2011 by -10%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for GERN is -2.59 vs. an industry ratio of -11.40, implying that they will have a higher earnings growth than their competitors in the same industry.

AcelRx Pharmaceuticals, Inc. ( ACRX ) is reporting for the quarter ending December 31, 2012. The drug company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-0.39. This value represents a 18.18% increase compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for ACRX is -3.41 vs. an industry ratio of 10.00.

Amicus Therapeutics, Inc. ( FOLD ) is reporting for the quarter ending December 31, 2012. The biomedical (gene) company's consensus earnings per share forecast from the 5 analysts that follow the stock is $-0.36. This value represents a -256.52% decrease compared to the same quarter last year. FOLD missed the consensus earnings per share in the 3rd calendar quarter of 2012 by -45.83%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for FOLD is -2.40 vs. an industry ratio of -11.40, implying that they will have a higher earnings growth than their competitors in the same industry.

GAIN Capital Holdings, Inc. ( GCAP ) is reporting for the quarter ending December 31, 2012. The investment bankers company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.05. This value represents a -200.00% decrease compared to the same quarter last year. The "days to cover" for this stock exceeds 12 days.The days to cover, as reported in the 2/28/2013 12:00:00 AM short interest update, increased214.28660386096 from previous report on2/15/2013 12:00:00 AM Zacks Investment Research reports that the 2012 Price to Earnings ratio for GCAP is 14.41 vs. an industry ratio of 14.00, implying that they will have a higher earnings growth than their competitors in the same industry.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , Earnings


NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

Stocks

Referenced

Most Active by Volume

57,375,820
  • $16.20 ▼ 0.80%
46,357,695
  • $102.13 ▲ 1.23%
39,856,106
  • $3.59 ▲ 0.84%
36,749,915
  • $19.21 ▲ 5.38%
35,094,671
  • $74.63 ▼ 1.75%
25,538,058
  • $48.06 ▼ 0.23%
24,241,250
  • $38.18 ▲ 1.03%
22,422,839
  • $11.20 ▲ 3.70%
As of 8/27/2014, 04:02 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com